Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer.

@article{Kesch2017MultiparametricMF,
  title={Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer.},
  author={Claudia Kesch and Viktoria Schuetz and Svenja Dieffenbacher and David Bonekamp and Boris Hadaschik and Markus Hohenfellner and Jan Philipp Radtke},
  journal={Current opinion in urology},
  year={2017},
  volume={28 2},
  pages={
          172-177
        }
}
PURPOSE OF REVIEW To discuss the timing, benefits, limitations and current controversies of multiparametric magnet resonance imaging (mpMRI) combined with fusion-guided biopsy and consider how additional incorporation of multivariable risk stratification might further improve prostate cancer diagnosis. RECENT FINDINGS MpMRI has been proven advantageous over standard practice for biopsy-naïve men and men with previous biopsy in large prospective studies providing level 1b evidence. Upfront… CONTINUE READING

Topics from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

Magnetic resonance imaging - transrectal ultrasound guided fusion biopsy to detect progression in patients with existing lesions on active surveillance for low and intermediate risk prostate cancer

P Recabal, M Assel, DD Sjoberg
  • J Urol
  • 2017

Magnetic resonance imaging – ultrasound fusion biopsy during prostate cancer active surveillance

X Meng, AB Rosenkrantz, N Mendhiratta
  • Eur Urol
  • 2017